Literature DB >> 23506174

The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤50 years of age.

Laura Rindom Krogsgaard1, Anne Line Engsbro, Peter Bytzer.   

Abstract

OBJECTIVE: Our aims were to investigate the prevalence and subtype distribution of irritable bowel syndrome (IBS) according to the Rome III criteria in Denmark, to describe the difference in symptom reporting between those with gastrointestinal (GI) symptoms not fulfilling Rome III for IBS compared to those classified as IBS, and furthermore to describe the proportion of consulters and formally diagnosed subjects.
MATERIAL AND METHODS: A web-based survey was carried out in January 2010. Questionnaires were emailed to a web panel (n = 19,567) representative of the general Danish population aged 18-50 years on gender, age, and geography. IBS and subtypes were estimated by the Rome III criteria.
RESULTS: Of 6112 responders, 979 (16%) fulfilled the Rome III criteria for IBS and had no organic diagnosis likely to explain their symptoms. Subtypes were: mixed IBS 36%, IBS with diarrhea 33%, IBS with constipation 18%, and unsubtyped IBS 11%. Those with GI symptoms, not fulfilling Rome III for IBS, had symptoms very similar to those classified as IBS, but symptoms were less frequent and of shorter duration. Of IBS subjects, 180/978 (18.4%) had consulted a doctor for GI symptoms within the past 3 months, but only 7.9% were diagnosed with IBS.
CONCLUSION: Symptoms compatible with IBS according to Rome III are highly prevalent in Denmark. A high proportion of sufferers are undiagnosed.

Entities:  

Mesh:

Year:  2013        PMID: 23506174     DOI: 10.3109/00365521.2013.775328

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  25 in total

1.  Multicenter observational study on functional bowel disorders diagnosed using Rome III diagnostic criteria in Japan.

Authors:  Masayoshi Ono; Mototsugu Kato; Shuichi Miyamoto; Momoko Tsuda; Takeshi Mizushima; Shouko Ono; Manabu Nakagawa; Katsuhiro Mabe; Soichi Nakagawa; Shuichi Muto; Yuichi Shimizu; Mineo Kudo; Shinichi Katsuki; Takashi Meguro; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2018-01-05       Impact factor: 7.527

Review 2.  Treatment of abdominal pain in irritable bowel syndrome.

Authors:  Tim Vanuytsel; Jan F Tack; Guy E Boeckxstaens
Journal:  J Gastroenterol       Date:  2014-05-21       Impact factor: 7.527

Review 3.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

Review 4.  Advances in the management of constipation-predominant irritable bowel syndrome: the role of linaclotide.

Authors:  Siegfried W B Yu; Satish S C Rao
Journal:  Therap Adv Gastroenterol       Date:  2014-09       Impact factor: 4.409

5.  Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.

Authors:  Louise Maagaard; Dorit V Ankersen; Zsuzsanna Végh; Johan Burisch; Lisbeth Jensen; Natalia Pedersen; Pia Munkholm
Journal:  World J Gastroenterol       Date:  2016-04-21       Impact factor: 5.742

Review 6.  Irritable bowel syndrome and small intestinal bacterial overgrowth: meaningful association or unnecessary hype.

Authors:  Uday C Ghoshal; Deepakshi Srivastava
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

7.  Epidemiology of Functional Gastrointestinal Disorders in Japan and in the World.

Authors:  Tadayuki Oshima; Hiroto Miwa
Journal:  J Neurogastroenterol Motil       Date:  2015-07-30       Impact factor: 4.924

Review 8.  Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders.

Authors:  Carlo Catassi; Julio C Bai; Bruno Bonaz; Gerd Bouma; Antonio Calabrò; Antonio Carroccio; Gemma Castillejo; Carolina Ciacci; Fernanda Cristofori; Jernej Dolinsek; Ruggiero Francavilla; Luca Elli; Peter Green; Wolfgang Holtmeier; Peter Koehler; Sibylle Koletzko; Christof Meinhold; David Sanders; Michael Schumann; Detlef Schuppan; Reiner Ullrich; Andreas Vécsei; Umberto Volta; Victor Zevallos; Anna Sapone; Alessio Fasano
Journal:  Nutrients       Date:  2013-09-26       Impact factor: 5.717

9.  Epidemiological features of irritable bowel syndrome and its subtypes among Iranian adults.

Authors:  Ammar Hassanzadeh Keshteli; Babak Dehestani; Hamed Daghaghzadeh; Peyman Adibi
Journal:  Ann Gastroenterol       Date:  2015 Apr-Jun

10.  Comparative effectiveness of 5-hydroxytryptamine 3 receptor antagonists in irritable bowel syndrome: a network meta-analysis of randomized controlled studies.

Authors:  Theodore Rokkas; Konstantinos Ekmektzoglou; Yaron Niv
Journal:  Ann Gastroenterol       Date:  2021-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.